|
|
|
|
LEADER |
01078caa a2200301 ir4500 |
001 |
NSK01000266383 |
003 |
HR-ZaNSK |
005 |
20070918093031.0 |
008 |
000927s1999 ci ||| ||eng |
015 |
|
|
|a HP99-6437
|2 HR
|
035 |
|
|
|9 (HR-ZaNSK)266658
|
035 |
|
|
|9 (HR-ZaNSK)400927083
|
035 |
|
|
|a (HR-ZaNSK)000266383
|
040 |
|
|
|a HR-ZaNSK
|b hrv
|c HR-ZaNSK
|e ppiak
|
041 |
0 |
|
|a eng
|
080 |
|
|
|a 577.27
|
080 |
|
|
|a 612.017
|
100 |
1 |
|
|a Toral, J. Isabella
|
245 |
1 |
0 |
|a Toxicity of major histocompatibility complex class II specific monoclonal antibodies :
|b audietur et altera pars /
|c J. Isabella Toral, Damir Vidović.
|
300 |
|
|
|b Ilustr.
|
504 |
|
|
|a Bibliografija: 20 jed.
|
650 |
|
7 |
|a Imunosupresija
|x Monoklonska protutijela
|2 nskps
|
650 |
|
7 |
|a Autoimune bolesti
|x Imunosupresija
|2 nskps
|
700 |
1 |
|
|a Vidović, Damir,
|c zdravstveni djelatnik
|
773 |
0 |
|
|t Croatian medical journal
|x 0353-9504
|g 40 (1999), 3 ; str. 353-356
|w nsk.(HR-ZaNSK)000006721
|
981 |
|
|
|z B9-10/99
|
998 |
|
|
|a trio0009
|a tomp0012
|c ikak0102
|c vebo0303
|
886 |
0 |
|
|2 unimarc
|b 00818naa2 2200229 450
|